Olmesartan medoxomil structure, CAS 144689-63-4

Olmesartan medoxomil

CAS Number144689-63-4

SynonymsBenicar; MFCD00914967; Olmetec; Benevas; Olmesartan Medoxomil

Molecular FormulaC29H30N6O6

Molecular Weight558.59

Purity98%

Density1.4±0.1 g/cm3

Boiling Point804.2±75.0 °C at 760 mmHg

Melting Point180°C

Flash Point

AppearanceWhite to off-white crystalline powder

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-9011759 Purity: 98%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 144689-63-4 ] Purity: 98% SDS Specification MoL

Chemical & Physical Properties
CAS Number144689-63-4
Catalog No.2A-9011759
Chinese Name奥美沙坦酯
SynonymsBenicar; MFCD00914967; Olmetec; Benevas; Olmesartan Medoxomil
Molecular FormulaC29H30N6O6
Molecular Weight558.59
Purity98
Density1.4±0.1 g/cm3
Boiling Point804.2±75.0 °C at 760 mmHg
Melting Point180°C
AppearanceWhite to off-white crystalline powder
Storage Condition-20°C Freezer
ApplicationOlmesartan medoxomil is a potent and selective angiotensin AT1 receptor inhibitor with an IC50 of 66.2 μM.
HTC2934999090
MDL NumberMFCD00944911
SMILESCCCC1=NC(C(O)(C)C)=C(C(OCC2=C(C)OC(O2)=O)=O)N1CC(C=C3)=CC=C3C4=CC=CC=C4C5=NN=NN5
InChI1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34)
InChI KeyUQGKUQLKSCSZGY-UHFFFAOYSA-N
NACRES CodeNA.24
UNSPSC41116107
MSDSmsds/11759_1_144689_63_4.pdf
Use ofOlmesartan medoxomil is a potent and selective angiotensin AT1 receptor inhibitor with IC50 of 66.2 μM. Properties Name Olmesartan medoxomil Synonym More Synonyms Olmesartan medoxomil Biological Activity Description Olmesartan medoxomil is a potent and selective angiotensin AT1 receptor inhibitor with IC50 of 66.2 μM. Related Catalog Signaling Pathways >> GPCR/G Protein >> Angiotensin Receptor Research Areas >> Cardiovascular Disease IC50: 66.2 μM (angiotensin II receptor)[1] In Vitro Inhibition of Arachidonic acid (AA) metabolism by angiotensin II receptor blockers (ARBs) is detected in a concentration-dependent manner with IC50 of Olmesartan (66.2 μM)[1]. Olmesartan medoxomil (OLM) is a potent and selective angiotensin AT1 receptor blocker[2]. References [2]. Shah S, et al. Simultaneous Quantitative Analysis of Olmesartan Medoxomil and Amlodipine Besylate in Plasma by High-performance Liquid Chromatography Technique. J Young Pharm. 2012 Apr;4(2):88-94. Chemical & Physical Properties Molecular Formula C29H30N6O6 Exact Mass 558.222656 PSA 162.16000 Index of Refraction 1.661 InChIKey UQGKUQLKSCSZGY-UHFFFAOYSA-N Safety Information Hazard Codes Xi RIDADR NONH for all modes of transport RTECS NI4014200 HS Code 2934999090 Synthetic Route Trityl Olmesart... 144690-92-6 Olmesartan medo... 144689-63-4 Trityl Olmesart... 144690-92-6 Olmesartan medo... 144689-63-4 Ethyl 4-(2-hydr... 144690-33-5 Olmesartan medo... 144689-63-4 Literature: Sankyo Company, Limited Patent: US5616599 A1, 1997 ; US 5616599 A Precursor & DownStream Precursor 10 CAS#:144690-92-6 Trityl Olmesart... CAS#:144690-33-5 Ethyl 4-(2-hydr... CAS#:80841-78-7 4-(Chloromethyl... CAS#:1020157-01-0 Trityl Olmesart... DownStream 1 CAS#:879562-26-2 Olmesartan medo...
Tax Rebate13.0%
SupervisionNone. MFN tariff: 6.5%. Ordinary tariff: 20.0%
Transport InfoProduct name: Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Related Products in API & Advanced Intermediates
Norfloxacine70458-96-72A-9011711
Norfluoxetine2A-3027952A-9011712
Norverapamil67018-85-32A-9011718
Ofloxacin82419-36-12A-9011747
Olmesartan144689-24-72A-9011758
Olsalazine15722-48-22A-9011765
Omeprazole sulfone2A-3028512A-9011768
Ondansetron 99614-02-52A-9011772
Ondansetron hydrochloride99614-01-42A-9011773
Ondansetron hydrochloride dihydrate103639-04-92A-9011774
Browse all API & Advanced Intermediates products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA